Erratum: Health Care-Associated infection after red blood cell transfusion: A systematic review and metaanalysis (JAMA - Journal of the American Medical Association (2014) 311:13 (1317-1326) DOI:10.1001/jama.2014.2726);Health care-associated infection after red blood cell transfusion: A systematic review and meta-analysis

JAMA

Volumn 311, Issue 13, 2014, Pages 1317-1326

  Rohde, Jeffrey M ^a   Dimcheff, Derek E ^a   Blumberg, Neil ^b   Saint, Sanjay ^a,c,d   Langa, Kenneth M ^a,c,d   Kuhn, Latoya ^c,d   Hickner, Andrew ^a,c   Rogers, Mary A M ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

BLOOD TRANSFUSION REACTION; CRITICALLY ILL PATIENT; ERYTHROCYTE TRANSFUSION; HEART DISEASE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL INFECTION; HUMAN; INCIDENCE; LEUKAPHERESIS; LOW BIRTH WEIGHT; MEDIASTINITIS; META ANALYSIS (TOPIC); ORTHOPEDIC SURGERY; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK REDUCTION; SEPSIS; SYSTEMATIC REVIEW; UPPER GASTROINTESTINAL BLEEDING; WOUND INFECTION;

CROSS INFECTION; ERYTHROCYTE TRANSFUSION; HUMANS; MEDIASTINITIS; PNEUMONIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; SEPSIS; SURGICAL WOUND INFECTION;

EID: 84897537450     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.14363     Document Type: Erratum

References (42)

1. US Department of Health and Human Services. National action plan to prevent healthcare-associated infections: roadmap to elimination. http://www.health.gov/hai/prevent-hai.asp. Accessed February 4, 2014.
2. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725-2732. (Pubitemid 46021509)
3. Boyce JM, Pittet D; Healthcare Infection Control Practices Advisory Committee; HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force; Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR Recomm Rep. 2002;51(RR-16):1-45.
4. Saint S, Greene MT, Kowalski CP, Watson SR, Hofer TP, Krein SL. Preventing catheter-associated urinary tract infection in the United States: a national comparative study. JAMA Intern Med. 2013;173(10):874-879.
5. Scott RD. The direct medical costs of healthcare-associated infections in US hospitals and the benefits of prevention. http://www.cdc.gov/HAI/pdfs/hai/ Scott-CostPaper.pdf. Accessed February 4, 2014.
6. Whitaker BI, Hinkins S. The 2011 national blood collection and utilization survey. http://www.bloodsurvey.org. Accessed 2/5/2014.
7. Lannan KL, Sahler J, Spinelli SL, Phipps RP, Blumberg N. Transfusion immunomodulation-the case for leukoreduced and (perhaps) washed transfusions. Blood Cells Mol Dis. 2013;50(1):61-68.
8. Buddeberg F, Schimmer BB, Spahn DR. Transfusion-transmissible infections and transfusion-related immunomodulation. Best Pract Res Clin Anaesthesiol. 2008;22(3):503-517.
9. Fergusson D, Khanna MP, Tinmouth A, Hébert PC. Transfusion of leukoreduced red blood cells may decrease postoperative infections: 2 meta-analyses of randomized controlled trials. Can J Anaesth. 2004;51(5):417-424.
10. Carson JL, Brooks MM, Abbott JD, et al. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J. 2013;165(6):964-971, e1.
11. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368(1):11-21.
12. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264-269, W64.
13. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2012;4:CD002042.
14. Gregersen M, Borris LC, Damsgaard EM. A liberal blood transfusion strategy after hip fracture surgery does not increase the risk of infection in frail elderly. Eur Geriatr Med. 2012;3 (supp 1):S74. doi:10.1016/j.eurger.2012. 07.139
15. Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Stat. 1950;21:607-611.
16. Kuhnert R, Böhning D. A comparison of 3 different models for estimating relative risk in meta-analysis of clinical trials under unobserved heterogeneity. Stat Med. 2007;26(11):2277-2296. (Pubitemid 46730249)
17. Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma. 2003;54(5):908-914. (Pubitemid 36758801)
18. Rogers MA, Blumberg N, Saint S, Langa KM, Nallamothu BK. Hospital variation in transfusion and infection after cardiac surgery: a cohort study. BMC Med. 2009;7:37.
19. Rogers MA, Blumberg N, Saint SK, Kim C, Nallamothu BK, Langa KM. Allogeneic blood transfusions explain increased mortality in women after coronary artery bypass graft surgery. Am Heart J. 2006;152(6):1028-1034. (Pubitemid 44856710)
20. Bracey AW, Radovancevic R, Riggs SA, et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion. 1999;39(10):1070-1077. (Pubitemid 29485322)
21. Hajjar LA, Vincent JL, Galas FR, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010;304(14):1559-1567.
22. Cholette JM, Rubenstein JS, Alfieris GM, Powers KS, Eaton M, Lerner NB. Children with single-ventricle physiology do not benefit from higher hemoglobin levels post cavopulmonary connection: results of a prospective, randomized, controlled trial of a restrictive versus liberal red-cell transfusion strategy. Pediatr Crit Care Med. 2011;12(1):39-45.
23. Cooper HA, Rao SV, Greenberg MD, et al. Conservative vs liberal red cell transfusion in acute myocardial infarction (the CRIT Randomized Pilot Study). Am J Cardiol. 2011;108(8):1108-1111.
24. Shehata N, Burns LA, Nathan H, et al. A randomized controlled pilot study of adherence to transfusion strategies in cardiac surgery. Transfusion. 2012;52(1):91-99.
25. de Gast-Bakker DH, de Wilde RB, Hazekamp MG, et al. Safety and effects of 2 red blood cell transfusion strategies in pediatric cardiac surgery patients: a randomized controlled trial. Intensive Care Med. 2013;39(11):2011-2019.
26. Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care: Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340(6):409-417. (Pubitemid 29084771)
27. Lacroix J, Hébert PC, Hutchison JS, et al; TRIPICU Investigators; Canadian Critical Care Trials Group; Pediatric Acute Lung Injury and Sepsis Investigators Network. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med. 2007;356(16):1609-1619.
28. Kirpalani H, Whyte RK, Andersen C, et al. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) vs liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr. 2006;149(3):301-307.
29. Carson JL, Terrin ML, Barton FB, et al. A pilot randomized trial comparing symptomatic vs hemoglobin level-driven red blood cell transfusions following hip fracture. Transfusion. 1998;38(6):522-529. (Pubitemid 28317227)
30. Grover M, Talwalkar S, Casbard A, et al. Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty. Vox Sang. 2006;90(2):105-112. (Pubitemid 43381498)
31. Foss NB, Kristensen MT, Jensen PS, Palm H, Krasheninnikoff M, Kehlet H. The effects of liberal vs restrictive transfusion thresholds on ambulation after hip fracture surgery. Transfusion. 2009;49(2):227-234.
32. So-Osman C, Nelissen R, Te Slaa R, Coene L, Brand R, Brand A. A randomized comparison of transfusion triggers in elective orthopaedic surgery using leucocyte-depleted red blood cells. Vox Sang. 2010;98(1):56-64.
33. Carson JL, Terrin ML, Noveck H, et al; FOCUS Investigators. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011;365(26):2453-2462.
34. Prick BW, Jansen AJG, Steegers EAP, et al. Transfusion policy after severe postpartum haemorrhage: a randomised non-inferiority trial [published online January 10, 2014]. BJOG. doi:10.1111/1471-0528.12531.
35. Karam O, Tucci M, Ducruet T, Hume HA, Lacroix J, Gauvin F; Canadian Critical Care Trials Group; PALISI Network. Red blood cell transfusion thresholds in pediatric patients with sepsis. Pediatr Crit Care Med. 2011;12(5):512-518.
36. Vichinsky EP, Haberkern CM, Neumayr L, et al; The Preoperative Transfusion in Sickle Cell Disease Study Group. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. N Engl J Med. 1995;333(4):206-213.
37. Howard J, Malfroy M, Llewelyn C, et al. The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial. Lancet. 2013;381(9870):930-938.
38. So-Osman C, Nelissen R, Brand R, et al. The impact of a restrictive transfusion trigger on post-operative complication rate and well-being following elective orthopaedic surgery: a post-hoc analysis of a randomised study. Blood Transfus. 2013;11(2):289-295.
39. Horvath KA, Acker MA, Chang H, et al. Blood transfusion and infection after cardiac surgery. Ann Thorac Surg. 2013;95(6):2194-2201.
40. Carson JL, Grossman BJ, Kleinman S, et al; Clinical Transfusion Medicine Committee of the AABB. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2012;157(1):49-58.
41. Centers for Disease Control and Prevention. CDC/NHSN surveillance definitions for specific types of infections. http://www.cdc.gov/nhsn/pdfs/ pscmanual/17pscnosinfdef-current.pdf. Accessed February 5, 2014.
42. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(5):426-435.